Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

TNF- alpha inhibitors.

J Mark Jackson1

  • 1University of Louisville Division of Dermatology, Dermatology Specialists Louisville, Kentucky 40202, USA. kmmjackson@aol.com

Dermatologic Therapy
|November 1, 2007
PubMed
Summary
This summary is machine-generated.

Tumor necrosis factor-alpha (TNF-alpha) inhibitors are crucial for treating inflammatory diseases. This review covers their production, administration, mechanisms, and efficacy in dermatologic conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stasis Dermatitis: The Burden of Disease, Diagnosis, and Treatment.

Dermatitis : contact, atopic, occupational, drug·2023
Same author

Cardiovascular comorbidities in atopic dermatitis: Potential implications for the use of Janus kinase inhibitors.

Journal of the American Academy of Dermatology·2023
Same author

Narrative Review of the Pathogenesis of Stasis Dermatitis: An Inflammatory Skin Manifestation of Venous Hypertension.

Dermatology and therapy·2023
Same author

Unmet needs for patients with seborrheic dermatitis.

Journal of the American Academy of Dermatology·2022
Same author

Evaluation of a First-in-Class Proteasome Inhibitor in Patients With Moderate to Severe Rosacea.

Journal of drugs in dermatology : JDD·2021
Same author

Treating Inflammation in Rosacea: Current Options and Unmet Needs.

Journal of drugs in dermatology : JDD·2020
Same journal

Increased Risk of Cutaneous T-Cell Lymphoma Development after Dupilumab Use for Atopic Dermatitis.

Dermatologic therapy·2024
Same journal

Correction to "Adjuvant PD-1 inhibitor versus high-dose interferon α-2b for Chinese patients with cutaneous and acral melanoma: A retrospective cohort analysis".

Dermatologic therapy·2022
Same journal

A case of erythema nodosum concomitant with ulcerative colitis relieved by tofacitinib.

Dermatologic therapy·2022
Same journal

A case report of vitiligo following toripalimab therapy for a patient with metastatic melanoma.

Dermatologic therapy·2022
Same journal

High versus low dose oral isotretinoin in the treatment of cutaneous and genital warts.

Dermatologic therapy·2022
Same journal

Evaluation of the efficacy and relapse rates of treatment protocols for moderate acne using isotretinoin based on the global acne grading system: Randomized, controlled, comparative study.

Dermatologic therapy·2022
See all related articles

Area of Science:

  • Immunology
  • Dermatology
  • Pharmacology

Background:

  • Tumor necrosis factor-alpha (TNF-alpha) is a key cytokine in inflammatory processes.
  • It plays a significant role in various cutaneous and systemic inflammatory diseases.
  • TNF-alpha inhibitors have emerged as vital therapeutic agents for these conditions.

Purpose of the Study:

  • To provide a comprehensive overview of TNF-alpha inhibitors.
  • To discuss their production, structure, and administration.
  • To detail their mechanisms of action, efficacy, and safety in dermatology.

Main Methods:

  • Literature review of TNF-alpha inhibitors.
  • Analysis of mechanisms of action.
  • Evaluation of clinical benefits in approved and non-approved dermatologic uses.

Related Experiment Videos

  • Review of side effect profiles and monitoring guidelines.

    • Main Results:

    • TNF-alpha inhibitors demonstrate significant efficacy in treating various inflammatory dermatoses.
    • Understanding their mechanisms of action is key to optimizing therapeutic outcomes.
    • Careful monitoring is essential due to potential side effects.

    Conclusions:

    • TNF-alpha inhibitors represent a significant advancement in managing inflammatory skin diseases.
    • Their targeted action provides substantial clinical benefits.
    • Ongoing research continues to refine their application and safety profile.